The global supply of Mo-99 relies on a limited number of research reactors and processing facilities. Its production is essential as medical diagnostic imaging techniques using Tc-99m account for approximately 80% of all nuclear medicine procedures worldwide. The short half-life's of the radioisotopes requires a continuous supply. Several severe disruptions have been experienced over the past decade. Fortunately, the situation encouraged the industry to develop new projects and new production routes. The current status of Mo-99 supply is described and the efforts made to achieve a reliable Tc-99m availability for nuclear medicine is summarized.
|Number of pages||4|
|Journal||ATW- International Journal of Nuclear Power|
|State||Published - 1 Jan 2016|